CSF2 and colorectal carcinoma: For example, in 2004, Mosolits et al. identified a promising anti-EpCAM vaccine: they treated 13 CRC patients with an anti-EpCAM vaccine (n = 7) or an anti-idiotypic antibody mimicking EpCAM (n = 6) in combination with GM-CSF.